Research ExplorerPublicationsA novel saline-based occlusion tool allows for dye-less cryo...

A novel saline-based occlusion tool allows for dye-less cryoballoon-based pulmonary vein isolation and fluoroscopy reduction

Standard

A novel saline-based occlusion tool allows for dye-less cryoballoon-based pulmonary vein isolation and fluoroscopy reduction. / Rottner, Laura; Obergassel, Julius; Borof, Katrin; My, Ilaria; Moser, Fabian; Lemoine, Marc; Wenzel, Jan-Per; Kirchhof, Paulus; Ouyang, Feifan; Reissmann, Bruno; Metzner, Andreas; Rillig, Andreas.

In: FRONT CARDIOVASC MED, Vol. 10, 2023, p. 1156500.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Rottner, L, Obergassel, J, Borof, K, My, I, Moser, F, Lemoine, M, Wenzel, J-P, Kirchhof, P, Ouyang, F, Reissmann, B, Metzner, A & Rillig, A 2023, 'A novel saline-based occlusion tool allows for dye-less cryoballoon-based pulmonary vein isolation and fluoroscopy reduction', FRONT CARDIOVASC MED, vol. 10, pp. 1156500. https://doi.org/10.3389/fcvm.2023.1156500

APA

Rottner, L., Obergassel, J., Borof, K., My, I., Moser, F., Lemoine, M., Wenzel, J-P., Kirchhof, P., Ouyang, F., Reissmann, B., Metzner, A., & Rillig, A. (2023). A novel saline-based occlusion tool allows for dye-less cryoballoon-based pulmonary vein isolation and fluoroscopy reduction. FRONT CARDIOVASC MED, 10, 1156500. https://doi.org/10.3389/fcvm.2023.1156500

Vancouver

Rottner L, Obergassel J, Borof K, My I, Moser F, Lemoine M et al. A novel saline-based occlusion tool allows for dye-less cryoballoon-based pulmonary vein isolation and fluoroscopy reduction. FRONT CARDIOVASC MED. 2023;10:1156500. https://doi.org/10.3389/fcvm.2023.1156500

Bibtex

@article{fc9bb26830734ef9b3bad8ac15ebf263,
title = "A novel saline-based occlusion tool allows for dye-less cryoballoon-based pulmonary vein isolation and fluoroscopy reduction",
abstract = "BACKGROUND: Cryoballoon (CB)- based pulmonary vein isolation (PVI) remains guided by fluoroscopy and dye. The novel saline injection-based occlusion tool allows for pulmonary vein (PV)-occlusion assessment without the need for dye injection.AIM: To compare KODEX-EPD guided CB-PVI using the novel saline injection-based workflow with conventional cryoablation for acute efficacy, fluoroscopy exposure and dye volume.METHODS: Consecutive atrial fibrillation (AF)- patients undergoing CB-PVI in conjunction with KODEX-EPD (CryoEPD group) were analyzed. Patients undergoing conventional CB-PVI (Cryo group) in the same time period acted as controls.RESULTS: One hundred forty patients [91/140 (65%) persistent AF] were studied. Seventy patients underwent CryoEPD procedures [64 ± 13 years, 21 (30%) female] and seventy patients underwent Cryo procedures [68 ± 10 years, 27 (39%) female].A total of 560 PVs were identified and successfully isolated. Mean procedure time was 66 ± 15 min for the CryoEPD group, and 65 ± 19 min for the Cryo group (p = 0.3). Fluoroscopy time (CryoEPD 6 ± 4 min; Cryo 13 ± 6 min, p < 0.001) and dose area product (CryoEPD 193 [111; 297] cGycm2; Cryo 381 [268; 614] cGycm2, p < 0.001) were lower in patients undergoing CryoEPD compared with Cryo procedures. No dye was needed in the CryoEPD group while 53 ± 18 ml dye per patient were administered for the Cryo group (p < 0.001). The overall complication rate was comparable between both groups (p = 0.5).CONCLUSION: KODEX-EPD guided AF-ablation enables dye-free CB-based PVI with reduced fluoroscopy exposure when compared to conventional CB-ablation, without differences in acute procedural outcomes or procedure duration.",
author = "Laura Rottner and Julius Obergassel and Katrin Borof and Ilaria My and Fabian Moser and Marc Lemoine and Jan-Per Wenzel and Paulus Kirchhof and Feifan Ouyang and Bruno Reissmann and Andreas Metzner and Andreas Rillig",
note = "{\textcopyright} 2023 Rottner, Obergassel, Borof, My, Moser, Lemoine, Wenzel, Kirchhof, Ouyang, Reissmann, Metzner and Rillig.",
year = "2023",
doi = "10.3389/fcvm.2023.1156500",
language = "English",
volume = "10",
pages = "1156500",
journal = "FRONT CARDIOVASC MED",
issn = "2297-055X",
publisher = "Frontiers Media S. A.",

}

RIS

TY - JOUR

T1 - A novel saline-based occlusion tool allows for dye-less cryoballoon-based pulmonary vein isolation and fluoroscopy reduction

AU - Rottner, Laura

AU - Obergassel, Julius

AU - Borof, Katrin

AU - My, Ilaria

AU - Moser, Fabian

AU - Lemoine, Marc

AU - Wenzel, Jan-Per

AU - Kirchhof, Paulus

AU - Ouyang, Feifan

AU - Reissmann, Bruno

AU - Metzner, Andreas

AU - Rillig, Andreas

N1 - © 2023 Rottner, Obergassel, Borof, My, Moser, Lemoine, Wenzel, Kirchhof, Ouyang, Reissmann, Metzner and Rillig.

PY - 2023

Y1 - 2023

N2 - BACKGROUND: Cryoballoon (CB)- based pulmonary vein isolation (PVI) remains guided by fluoroscopy and dye. The novel saline injection-based occlusion tool allows for pulmonary vein (PV)-occlusion assessment without the need for dye injection.AIM: To compare KODEX-EPD guided CB-PVI using the novel saline injection-based workflow with conventional cryoablation for acute efficacy, fluoroscopy exposure and dye volume.METHODS: Consecutive atrial fibrillation (AF)- patients undergoing CB-PVI in conjunction with KODEX-EPD (CryoEPD group) were analyzed. Patients undergoing conventional CB-PVI (Cryo group) in the same time period acted as controls.RESULTS: One hundred forty patients [91/140 (65%) persistent AF] were studied. Seventy patients underwent CryoEPD procedures [64 ± 13 years, 21 (30%) female] and seventy patients underwent Cryo procedures [68 ± 10 years, 27 (39%) female].A total of 560 PVs were identified and successfully isolated. Mean procedure time was 66 ± 15 min for the CryoEPD group, and 65 ± 19 min for the Cryo group (p = 0.3). Fluoroscopy time (CryoEPD 6 ± 4 min; Cryo 13 ± 6 min, p < 0.001) and dose area product (CryoEPD 193 [111; 297] cGycm2; Cryo 381 [268; 614] cGycm2, p < 0.001) were lower in patients undergoing CryoEPD compared with Cryo procedures. No dye was needed in the CryoEPD group while 53 ± 18 ml dye per patient were administered for the Cryo group (p < 0.001). The overall complication rate was comparable between both groups (p = 0.5).CONCLUSION: KODEX-EPD guided AF-ablation enables dye-free CB-based PVI with reduced fluoroscopy exposure when compared to conventional CB-ablation, without differences in acute procedural outcomes or procedure duration.

AB - BACKGROUND: Cryoballoon (CB)- based pulmonary vein isolation (PVI) remains guided by fluoroscopy and dye. The novel saline injection-based occlusion tool allows for pulmonary vein (PV)-occlusion assessment without the need for dye injection.AIM: To compare KODEX-EPD guided CB-PVI using the novel saline injection-based workflow with conventional cryoablation for acute efficacy, fluoroscopy exposure and dye volume.METHODS: Consecutive atrial fibrillation (AF)- patients undergoing CB-PVI in conjunction with KODEX-EPD (CryoEPD group) were analyzed. Patients undergoing conventional CB-PVI (Cryo group) in the same time period acted as controls.RESULTS: One hundred forty patients [91/140 (65%) persistent AF] were studied. Seventy patients underwent CryoEPD procedures [64 ± 13 years, 21 (30%) female] and seventy patients underwent Cryo procedures [68 ± 10 years, 27 (39%) female].A total of 560 PVs were identified and successfully isolated. Mean procedure time was 66 ± 15 min for the CryoEPD group, and 65 ± 19 min for the Cryo group (p = 0.3). Fluoroscopy time (CryoEPD 6 ± 4 min; Cryo 13 ± 6 min, p < 0.001) and dose area product (CryoEPD 193 [111; 297] cGycm2; Cryo 381 [268; 614] cGycm2, p < 0.001) were lower in patients undergoing CryoEPD compared with Cryo procedures. No dye was needed in the CryoEPD group while 53 ± 18 ml dye per patient were administered for the Cryo group (p < 0.001). The overall complication rate was comparable between both groups (p = 0.5).CONCLUSION: KODEX-EPD guided AF-ablation enables dye-free CB-based PVI with reduced fluoroscopy exposure when compared to conventional CB-ablation, without differences in acute procedural outcomes or procedure duration.

U2 - 10.3389/fcvm.2023.1156500

DO - 10.3389/fcvm.2023.1156500

M3 - SCORING: Journal article

C2 - 37034336

VL - 10

SP - 1156500

JO - FRONT CARDIOVASC MED

JF - FRONT CARDIOVASC MED

SN - 2297-055X

ER -